🔴 Conexeu Sciences is trading 5% down with no clear catalyst identified

Conexeu Sciences is trading 5.04% down at $3.58, with no company-specific announcement identified to explain the October 13, 2026 decline.

• The latest company update, dated October 6, concerned progress toward a planned FDA 510(k) submission in Q1 2027.
• Biotech ETF XBI is down 2.01%, a possible contributing backdrop. The broad market was only slightly lower, and no clear catalyst has been identified for Conexeu Sciences’ larger move.